Ketorolac Market

Ketorolac Market Size, Share & Industry Analysis, By Application (Post-Surgical Pain Management, Acute Pain Relief for Conditions like Arthritis and Dental Procedures, Short-Term Treatment for Moderate to Severe Pain), By Formulation Type (Injectable Solutions for Intravenous or Intramuscular Administration, Oral Tablets for Outpatient Pain Management, Ophthalmic Formulations for Post-Operative Eye Surgery Pain Relief), Key End-Use Industry (Hospitals, Clinics, Pharmaceutical Manufacturers, Outpatient Settings), and Forecast, 2025–2035

The Ketorolac market is projected to grow steadily between 2025 and 2035, at a CAGR of 4.5%. This growth is primarily driven by the rising number of surgical procedures, increasing demand for effective pain management treatments, and the growing geriatric population requiring pain relief. Ketorolac’s effectiveness in post-surgical pain management and its widespread use in various formulations significantly contribute to its adoption across pharmaceutical manufacturers.

Regionally, North America leads the Ketorolac market owing to high demand for pain relief in post-surgical patients and the presence of well-established pharmaceutical companies. Europe follows closely with a strong healthcare infrastructure and increasing use of Ketorolac in managing acute pain, especially in the elderly population. The Asia-Pacific region is anticipated to experience the fastest growth, driven by rising healthcare access, increased surgical procedures, and demand for cost-effective pain management solutions in countries like India and China.

The Ketorolac market benefits from continuous innovations in API production, cost-effective manufacturing processes, and the expansion of pharmaceutical applications. However, challenges such as regulatory hurdles, price sensitivity in emerging markets, and competition from alternative pain management options are expected to influence market dynamics. Despite these challenges, the growing need for effective post-surgical pain management continues to drive the global Ketorolac market.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Ketorolac
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Application
    • Post-surgical pain management
    • Acute pain relief for conditions like arthritis and dental procedures
    • Short-term treatment for moderate to severe pain
  • By Formulation Type
    • Injectable solutions for intravenous or intramuscular administration.
    • Oral tablets for outpatient pain management.
    • Ophthalmic formulations for post-operative eye surgery pain relief.
  • Key End-Use Industries
    • Hospitals
    • Clinics
    • Pharmaceutical Manufacturers
    • Outpatient Settings

 

  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America and Middle East and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies

 

What is Ketorolac?
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) primarily used for its analgesic properties in the treatment of moderate to severe pain. It is widely used in post-surgical pain management and for conditions like arthritis and dental procedures.
What is the market size for Ketorolac?
The Ketorolac market is projected to grow steadily between 2025 and 2035, with a CAGR of 4.5%. The market is driven by increasing demand for pain management in surgical patients and a growing geriatric population.
What are the drivers for the Ketorolac Market?
Key drivers include an increasing number of surgeries requiring effective pain relief, rising incidences of arthritis and other painful conditions, and the growing geriatric population. Also, the widespread adoption of Ketorolac in various formulations to manage moderate to severe pain is fueling market growth.
Who are the key players operating in the Ketorolac Market?
Major players include Pfizer Inc., Novartis International AG, Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Mylan N.V., and Amgen Inc.
Which region would exhibit the fastest growth in the Ketorolac Market?
The Asia-Pacific region is expected to exhibit the fastest growth in the Ketorolac market. This is attributed to increasing healthcare access, rising demand for pain management treatments, and the growth of biopharmaceutical manufacturing in countries like China, India, and South Korea.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.